PA
Perceptive Advisors’s Lyra Therapeutics LYRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.29M | Sell |
255,150
-12,502,412
| -98% | -$112M | 0.08% | 69 |
|
|
2025
Q1 | $1.61M | Hold |
12,757,562
| – | – | 0.06% | 72 |
|
|
2024
Q4 | $2.63M | Hold |
12,757,562
| – | – | 0.07% | 82 |
|
|
2024
Q3 | $3.28M | Hold |
12,757,562
| – | – | 0.07% | 82 |
|
|
2024
Q2 | $3.53M | Hold |
12,757,562
| – | – | 0.09% | 85 |
|
|
2024
Q1 | $79.4M | Hold |
12,757,562
| – | – | 1.39% | 24 |
|
|
2023
Q4 | $66.8M | Hold |
12,757,562
| – | – | 1.49% | 21 |
|
|
2023
Q3 | $49.9M | Hold |
12,757,562
| – | – | 1.66% | 17 |
|
|
2023
Q2 | $52.4M | Buy |
12,757,562
+3,610,832
| +39% | +$14.8M | 1.52% | 18 |
|
|
2023
Q1 | $18.4M | Hold |
9,146,730
| – | – | 0.54% | 47 |
|
|
2022
Q4 | $28.7M | Hold |
9,146,730
| – | – | 0.81% | 37 |
|
|
2022
Q3 | $45.8M | Hold |
9,146,730
| – | – | 1.33% | 22 |
|
|
2022
Q2 | $51.7M | Buy |
9,146,730
+5,924,170
| +184% | +$33.5M | 1.62% | 13 |
|
|
2022
Q1 | $13M | Hold |
3,222,560
| – | – | 0.26% | 71 |
|
|
2021
Q4 | $14.1M | Hold |
3,222,560
| – | – | 0.22% | 77 |
|
|
2021
Q3 | $29.4M | Hold |
3,222,560
| – | – | 0.43% | 59 |
|
|
2021
Q2 | $25.9M | Hold |
3,222,560
| – | – | 0.34% | 73 |
|
|
2021
Q1 | $37.3M | Sell |
3,222,560
-1
| -0% | -$12 | 0.47% | 51 |
|
|
2020
Q4 | $36.7M | Hold |
3,222,561
| – | – | 0.39% | 56 |
|
|
2020
Q3 | $36M | Hold |
3,222,561
| – | – | 0.53% | 49 |
|
|
2020
Q2 | $36.5M | Buy |
+3,222,561
| New | +$36.5M | 0.59% | 40 |
|